Researchers in Germany believe that MR imaging should be included among the World Health Organization’s options for diagnosing sporadic Creutzfeldt-Jakob disease (sCJD), which is associated with exposure to mad cow disease.
Researchers in Germany believe that MR imaging should be included among the World Health Organization's options for diagnosing sporadic Creutzfeldt-Jakob disease (sCJD), which is associated with exposure to mad cow disease.
Principal investigator Dr. Henriette Tschampa and colleagues at the Clinical University of Bonn enrolled 193 consecutive patients suspected of having the condition. All the patients had previously been examined by a neurologist from the German CJD Surveillance Unit in a study that took place between 1999 and 2002.
In addition to evaluating MRI's utility, the investigators paired study results with those of electroencephalography and 14-3-3 protein analysis. They found that MR provided a reliable diagnosis of sCJD.
In 442 scans, MR's sensitivity and specificity were nearly 70% and 85%, respectively, in patients with a clinical or postmortem sCJD diagnosis. Sensitivity and specificity for EEG and 14-3-3 protein analysis were 32% and 94%, and 91% and 44%, respectively.
MR's imaging protocol included T2-weighted, FLAIR, diffusion-weighted, and proton density-weighted sequences. Three independent observers compared and rated the studies and reached high agreement.
Even though MR's interpretation could require some effort, it provides useful information that could narrow down an sCJD diagnosis, it is 100% noninvasive, and it has an edge over diagnostic alternatives plagued by high false-positive rates. MRI is not among WHO's sanctioned diagnostic tests for sCJD, but the time to incorporate it has come, Tschampa said.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.